HAEMONETICS CORP — Director's Dealing 2015

Jul 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-07-21

Reporting Person: FOOTE SUSAN BARTLETT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-21	Common Stock	A	4337.0	$0.0	Acquired	16670	Direct

Footnotes

F1: Restricted Stock Unit Grant which vest 100% on the first anniversary of the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.